Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Identifying potential patient safety issues from the Federal Electronic Health Record Surveillance Program

Pacheco TB, Hettinger AZ, Ratwani RM. Identifying Potential Patient Safety Issues From the Federal Electronic Health Record Surveillance Program. JAMA. 2019;322(23):2339-2340. doi:10.1001/jama.2019.17242.

Save
Print
January 29, 2020
Pacheco TB, Hettinger AZ, Ratwani RM. JAMA. 2019;322(23):2339-2340.
View more articles from the same authors.

The authors analyzed national EHR surveillance data to identify whether reported issues with EHR products that meet Federal standards carry patient safety risks in actual use. Examples include not restricting oral liquid medication dosing to milliliters or having inaccurate standard drug names (RxNorm codes). The study found that nearly 42% of EHR products that underwent surveillance in response to a reported issue were confirmed as having a possible patient harm risk.

Save
Print
Cite
Citation

Pacheco TB, Hettinger AZ, Ratwani RM. Identifying Potential Patient Safety Issues From the Federal Electronic Health Record Surveillance Program. JAMA. 2019;322(23):2339-2340. doi:10.1001/jama.2019.17242.